Gold tier: mechanically validated evidence, with its primary source.
1,197 evidence items · page 40 / 48
0.4 risk_ratioIn the study-level meta-analysis, treatment was associated with a reduction in clinical malaria with a risk ratio of 0.40.
Malipaludismepublished 2020The Lancet. Global healtheurope_pmcdocument of 6 observationsDOI 10.1016/s2214-109x(20)30325-9
66 %The efficacy of L9LS against Plasmodium falciparum infection, as compared with placebo, was 66% with the 150-mg dose.
Malipaludismepublished 2024The New England journal of medicineeurope_pmcdocument of 7 observations
113 per_1000_person-yearsThere were 113 events of uncomplicated clinical malaria per 1000 person-years at risk in the combination group.
Malipaludismepublished 2021The New England journal of medicineeurope_pmcdocument of 10 observations
11.18 %The prevalence of sickle cell trait (HbAS) among 3648 newborns in Mali was 11.18%.
Malitrait drépanocytaireobserved April–August 2021HAL · Unilimdocument of 103 observations
5 foldAnti-AMA-1 antibodies increased significantly in both malaria vaccine groups, peaking at nearly 5-fold higher than baseline in the half-dose group.
Malipaludismepublished 2008PloS oneeurope_pmcdocument of 2 observations
0.02 %La prévalence des gamétocytes chez les enfants de moins d’un an était de 0,020 %.
MalipaludismeHAL · Unilimdocument of 214 observations
21 %Entre 2016 et 2019, le nombre de décès associés au paludisme au Mali a diminué de 21 %, passant de 0,76 à 0,59 décès pour 1000 habitants.
Malipaludismeobserved 2016 à 2019HAL · Unilimdocument of 214 observations
16 joursUne période pré-patente de 16 jours, considérée comme la plus courte, a été signalée pour une souche ouest-africaine de P. malariae.
MalipaludismeHAL · Unilimdocument of 214 observations
50 %Non-falciparum species were primarily detected in adolescents (10–14 years) with frequencies above 50%.
Malinon-falciparum Plasmodium speciespublished 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 16 observations
Le paludisme au Mali est saisonnier avec un pic d'incidence des cas cliniques et de mortalité entre septembre et novembre.
Malipaludismeobserved septembre–novembreHAL · Unilimdocument of 214 observations
7.32 %Dans le dépistage actif, la prévalence du paludisme était de 7,32 % chez les enfants âgés de 10 à 14 ans.
MalipaludismeHAL · Unilimdocument of 214 observations
15 odds_ratioThe odds ratio for greater susceptibility to severe malaria in heterozygous G6PD (A−) females with sickle cell trait was 15.
MaliG6PD (A−) deficiency · paludisme · trait drépanocytairepublished 2011American Journal of HematologyOpenAlexdocument of 9 observationsDOI 10.1002/ajh.22093
97.8 %A randomized, phase 3 study comparing artemether-lumefantrine (AL) Dispersible to crushed AL tablets in 899 African children reported a PCR-corrected cure rate of 97.8% at day 28 for AL Dispersible.
Malipaludismepublished 2015Antimicrobial agents and chemotherapyeurope_pmcdocument of 3 observations
229,000,000 casEn 2019, le nombre de cas de paludisme s'élevait à 229 millions de cas détectés.
Malipaludismeobserved 2019HAL · Unilimdocument of 214 observations
92.1 %In Mali, a retrospective study conducted at CHU Gabriel Touré in Bamako between 2014 and 2018 showed a reduction in cerebral malaria frequency from 92.1% to 83.5% after SMC introduction.
Malipaludismeobserved 2014–2018HAL · Unilimdocument of 147 observations
9,941 patientsBetween July 2022 and October 2023, a total of 9941 patients with severe respiratory illness were enrolled, of whom 588 (5.9%) tested positive for SARS-CoV-2.
Kenya · MaliCOVID-19observed July 2022 to October 2023published 2026VaccinePubMeddocument of 8 observations
79.8 %The parasite positivity rate decreased from 79.8% on day 1 to 9.5% on day 2 for artemether-lumefantrine.
Malipaludismepublished 2018Malaria journaleurope_pmcdocument of 4 observations
5,000 nouveau-nésAu Mali, le criblage néonatal estime le nombre de naissances d’enfants drépanocytaires entre 5 000 et 6 000 par an.
MalidrépanocytoseHAL · Unilimdocument of 202 observations
2 mg/LA synthetic aminosterol derivative (ASD) showed in vitro activity against dermatophytes with minimum inhibitory concentrations (MICs) ranging from 2 to 8 mg/L.
Malidermatophyte infectionspublished 2013Medical mycologyeurope_pmcdocument of 2 observations
70 %A pilot study conducted in the central region of Segou found IRS reduced malaria incidence by 70%.
MalipaludismeHAL · Unilimdocument of 111 observations
For the artesunate-amodiaquine and artesunate-sulfadoxine/pyrimethamine arms, gametocyte carriage increased on Day 3 and remained constant until Day 7 before decreasing afterward.
Maligametocyte carriage · paludismeobserved 2005–2007published 2018African journal of laboratory medicineeurope_pmcdocument of 2 observations
30 %In Mali, the model estimate of ONNV prevalence is 30%.
MaliO'nyong-nyong viruspublished 2021Nature communicationseurope_pmcdocument of 6 observations
Parasite densities during disease episodes were lower in the sulfadoxine-pyrimethamine group.
Malipaludismepublished 2002The American journal of tropical medicine and hygieneeurope_pmcdocument of 4 observationsDOI 10.4269/ajtmh.2002.67.604
0.8 %P. ovale a une prévalence allant de 0,8 % à 5 % en Afrique subsahélienne.
MalipaludismeHAL · Unilimdocument of 214 observations
27 %Of the 300 children, 82 (27%) had at least one episode of asymptomatic Plasmodium parasitemia.
Malipaludismepublished 2025New microbes and new infectionseurope_pmcdocument of 2 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.